期刊文献+

盐酸奥洛他定联合0.1%环孢霉素A滴眼液治疗春季角结膜炎的研究 被引量:1

Study of Olopatadine Hydrochloride Combined With 0.1% Cyclosporine A Eye Drops for the Treatment of Vernal Keratoconjunctivitis
下载PDF
导出
摘要 目的分析探讨盐酸奥洛他定联合0.1%环孢霉素A滴眼液治疗春季角结膜炎的临床效果。方法选取2014年1月~2015年12月我院收治的273例春季角结膜炎患者,采用随机数字表法分为两组。对照组患者采用盐酸奥洛他定治疗,观察组患者采用盐酸奥洛他定联合0.1%环孢霉素A滴眼液治。分析比较两组患者的治疗有效率。结果治疗后,观察组患者的临床症状评分和体征评分小于对照组,差异有统计学意义(P〈0.05);治疗有效率大于对照组,差异有统计学意义(P〈0.05)。结论相对于单纯盐酸奥洛他定治疗,联合0.1%环孢霉素A滴眼液对患者的治疗效果更优。 Objective To analyze the clinical effect of olopatadine hydrochloride combined with 0.1% cyclosporin A eye drops in the treatment of vernal keratoconjunctivitis.Methods273 cases of patients with spring angle conjunctivitis from January 2014 to December 2015 in our hospital were randomly divided into two groups. The control group was treated with olopatadine hydrochloride,observation group were treated with olopatadine hydrochloride combined with 0.1% cyclosporin A eye drops. The effect of two groups were analyzed and compared. ResultsAfter treatment,the clinical symptom and sign scores in observation group were lower than the control group(P〈0.05),while the effective rate was higher than the control group(P〈0.05). ConclusionCompared with olopatadine hydrochloride,the combined therapy with 0.1% cyclosporin A eye drops resulted a better effect.
作者 王振宇 张旭
出处 《中国卫生标准管理》 2016年第21期84-85,共2页 China Health Standard Management
关键词 盐酸奥洛他定 环孢霉素A滴眼液 春季角结膜炎 Olopatadine hydrochloride Cyclosporin A eyedrops Vernal keratoconjunctivitis
  • 相关文献

参考文献8

二级参考文献65

  • 1费文雷,陈家祺,王智崇,陈龙山,孙明霞.FK506局部治疗顽固性春季角结膜炎[J].中国实用眼科杂志,2004,22(11):916-918. 被引量:18
  • 2史伟云,刘廷,谢立信,王身国.FK506缓释系统前房植入抑制兔高危角膜移植术后的免疫排斥反应[J].中华眼科杂志,2006,42(4):299-304. 被引量:18
  • 3Montan PG, Biberfeld PJ,Scheynius A. IgE,IgE recep tots, and other immunocytochemical markers in atopic and nonatopic pa- tientswith vernal keratoconjunctivitls. Ophthalmology, 1995, 102: 725 -732.
  • 4CalderVL, Jolly G, HingoraniM, et al. Cytokine production and mRNA expression by conjunctivel T cell lines in chronic allec eye disease. Clin Eye Allerg,1999,29:1214-1222.
  • 5Shii D, Nakagawa S, Shinomiya K, et al. Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction. Curt Eye Res, 2009,34(6) :426-437.
  • 6Keklikci U, Soker SI, sakalar YB,et al. efficacy d topica cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjuncfivitis in children. Jpn J Ophthalmol,2008,52:357-362.
  • 7Sakuma S, Higashi Y, Soato N, et al. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system ( Comparison with steroids ). lnt Immunopharma~ol 2001 ; 1 ( 6 ) : 1219-1226.
  • 8韩锐,贾立华,刘泽源,等.几种常见免疫抑制剂的研究进展.药学专论,2011;20(13):1-4.
  • 9Peters DH, Fitton A, Plosker GL, et al. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993 ;46(4) :746-794.
  • 10Atlas-fox L, Barkana Y, Iskhakov V, et al. Topical lacrolimus 0.03% onitment for intractable allergic conjunctivitis:an open-label pilot study. Curr Eye Res 2008 ;33(7) :545-549.

同被引文献17

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部